Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
In Saudi Arabia, malignant primary brain tumors are reported in ~2% to 3% of all tumors in adults. GBM is commonly diagnosed among malignant primary brain tumors. Another study estimated the incidence of primary CNS neoplasms as 3.1 per 100,000 population in the Eastern Province of Saudi Arabia and 2.9/100,000 population in Saudi nationals.
The National Neurologic Institute in Saudi Arabia provides comprehensive medical care to patients with neurological diseases. The capacity of the institute has significantly increased in the last decade and so has the offered modern technologies. King Abdulaziz University Hospital has reported providing superior image-guided radiation therapy and volumetric modulated arc therapy for the treatment of GBM.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia glioblastoma multiforme treatment market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account